Robert Steven Busch MD
Diabetes, Lipid Metabolism, Thyroid
Assistant Clinical Professor, Endocrinology, Albany Medical College
Join to View Full Profile
1365 Washington AveSte 300Albany, NY 12206
Phone+1 518-489-4704
Fax+1 518-489-0512
Dr. Busch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Busch is an endocrinologist based in Albany, NY, with subspecialties in diabetes, lipid metabolism, and thyroid disorders. He completed his medical education at the Perelman School of Medicine at the University of Pennsylvania and a fellowship in endocrinology at Albany Medical Center. Dr. Busch has conducted extensive research, with publications in renowned journals such as Nature Medicine and BMJ Open, focusing on type 2 diabetes and chronic kidney disease. His clinical trials have explored treatments for diabetic kidney disease and the impact of medications on glycemic control. He has been recognized by Hudson Valley Magazine and achieved meaningful use certification, as well as being a Fellow of the American Association of Clinical Endocrinology.
Education & Training
Albany Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1984
N Shore U1981
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1978 - 1979
Perelman School of Medicine at the University of PennsylvaniaClass of 1978
Certifications & Licensure
NY State Medical License 1979 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Hudson Valley Magazine Castle Connolly, 2012-2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
- Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Publications & Presentations
PubMed
- 3 citationsPrevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.John B Buse, Steven E Kahn, Vanita R Aroda, Richard J Auchus, Timothy Bailey
Diabetes Care. 2025-12-01 - 3 citationsInadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.Ralph A DeFronzo, Vivian Fonseca, Vanita R Aroda, Richard J Auchus, Timothy Bailey
Diabetes Care. 2025-12-01 - 74 citationsEffects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.Johannes F E Mann, Peter Rossing, George Bakris, Nicolas Belmar, Heidrun Bosch-Traberg
Nature Medicine. 2024-10-01
Press Mentions
Endocrinology Clinical Trials Program ThrivingMay 4th, 2022
50 Things Doctors Would Tell Their Own MothersAugust 9th, 2019
Diabetes Increases the Risk of Heart Failure More in Women Than in MenJuly 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
